|By PR Newswire||
|August 19, 2014 09:30 AM EDT||
TARRYTOWN, N.Y., Aug. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
- Sanofi and Regeneron will host an IR Thematic Conference Call on Alirocumab at 8:30 a.m. Eastern Time on Tuesday, September 2, 2014
- Baird 2014 Healthcare Conference at 4:05 p.m. Eastern Time on Wednesday, September 3, 2014
- Citi's 9th Annual Biotech Conference at 10:00 a.m. Eastern Time on Thursday, September 4, 2014
- Morgan Stanley Global Healthcare Conference at 8:45 a.m. Eastern Time on Monday, September 8, 2014
The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
Manisha Narasimhan, Ph.D.
SOURCE Regeneron Pharmaceuticals, Inc.
Sep. 25, 2016 06:30 AM EDT Reads: 2,793
Sep. 25, 2016 05:45 AM EDT Reads: 1,601
Sep. 25, 2016 05:30 AM EDT Reads: 975
Sep. 25, 2016 04:45 AM EDT Reads: 1,498
Sep. 25, 2016 04:15 AM EDT Reads: 1,677
Sep. 25, 2016 04:15 AM EDT Reads: 1,380
Sep. 25, 2016 03:15 AM EDT Reads: 3,349
Sep. 25, 2016 03:00 AM EDT Reads: 1,470
Sep. 25, 2016 02:45 AM EDT Reads: 1,708
Sep. 25, 2016 02:45 AM EDT Reads: 873
Sep. 25, 2016 02:15 AM EDT Reads: 1,210
Sep. 25, 2016 12:45 AM EDT Reads: 1,036
Sep. 25, 2016 12:45 AM EDT Reads: 1,929
Sep. 25, 2016 12:30 AM EDT Reads: 1,597
Data is an unusual currency; it is not restricted by the same transactional limitations as money or people. In fact, the more that you leverage your data across multiple business use cases, the more valuable it becomes to the organization. And the same can be said about the organization’s analytics. In his session at 19th Cloud Expo, Bill Schmarzo, CTO for the Big Data Practice at EMC, will introduce a methodology for capturing, enriching and sharing data (and analytics) across the organizati...
Sep. 24, 2016 09:45 PM EDT Reads: 1,612